Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Accumulated Expenses (2016 - 2025)

National Healthcare (NHC) has disclosed Accumulated Expenses for 16 consecutive years, with $103.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 234.18% year-over-year to $103.9 million, compared with a TTM value of $103.9 million through Dec 2025, up 234.18%, and an annual FY2025 reading of $103.9 million, up 234.18% over the prior year.
  • Accumulated Expenses was $103.9 million for Q4 2025 at National Healthcare, up from $32.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $106.7 million in Q4 2021 and bottomed at $30.5 million in Q4 2023.
  • Average Accumulated Expenses over 5 years is $51.9 million, with a median of $31.4 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses soared 244.71% in 2021, then crashed 70.6% in 2022.
  • Year by year, Accumulated Expenses stood at $106.7 million in 2021, then plummeted by 70.6% to $31.4 million in 2022, then decreased by 2.6% to $30.5 million in 2023, then grew by 1.79% to $31.1 million in 2024, then soared by 234.18% to $103.9 million in 2025.
  • Business Quant data shows Accumulated Expenses for NHC at $103.9 million in Q4 2025, $32.5 million in Q3 2025, and $32.0 million in Q2 2025.